vimarsana.com

Her2 Breast Cancer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Screening and Treatment Reduce Breast Cancer Mortality

Simulation models indicate that breast cancer screening and treatment were associated with a 58% reduction in mortality, based on data collected between 1975 and 2019.

United statesSurveillance modeling networkNational comprehensive cancer network outcomesCancer interventionBreast cancerAlignant breast neoplasmBreast carcinomaBreast cancer screeningAdvanced breast cancerMetastatic breast carcinomaMetastatic breast cancerDvanced bcEtastatic bcEtastatic breast cancer mbcBc metastatic breast cancerAlignant neoplasia

HER2CLIMB-02: Primary Analysis of a Randomized, Double-blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-positive Metastatic Breast Cancer

Sara A. Hurvitz, MD, presents data from the phase 3 HER2CLIMB-02 study investigating tucatinib and trastuzumab emtansine in patients with previously treated HER2+ metastatic breast cancer.

San antonioUnited statesSaraa hurvitzTrastuzumab emtansinePrimary analysisDouble blind phasePreviously treatedMetastatic breastPartnership withAntonio breast cancer symposiumBreast cancerHer2 metastatic breast cancerHer2 positive metastatic breast cancerHer2 breast cancerHer2 positive breast cancerHer2climb 02

Study Validates Breast Recurrence Score Across Ethnic Groups

A recent study validated the predictive biomarker's effectiveness in guiding treatment decisions for diverse groups.

United statesUniversity of illinoisHsiao ching huangUniversity of illinois college pharmacyJournal of the national comprehensive cancer networkPacific islanderHispanic blackHispanic whiteIllinois collegeNational comprehensive cancerBreast cancerAlignant breast neoplasmBreast carcinomaHer2 negative breast cancerHer2 breast cancerMammary gland

Is Axillary Surgery for Abemaciclib Candidacy Overused?

Many women with HR–positive, HER2–negative breast cancer may be exposed to unnecessary axillary surgery, new data show.

United statesFox chase cancer centerAustind williamsBreast cancerAlignant breast neoplasmBreast carcinomaLymph node dissectionLymph nodesHer2 negative breast cancerHer2 breast cancerGenomics genomic medicineAlignant neoplasiaAlignant neoplasmMammary glandEpidermal growth factor receptorGfr epidermal growth factor receptor

The Latest Findings on Major Breast Cancer Trials

Here's a roundup of the most recent data from five phase 3 trials presented at SABCS 2023.

United statesSan franciscoJo chienGabriel hortobagyiUniversity of californiaMd anderson cancer centerUniversity of frankfurtAntonio breast cancer symposiumMedical newsCancer centerSibylle loiblBreast cancerAlignant breast neoplasmBreast carcinomaBiologic therapyAntineoplastic drug

vimarsana © 2020. All Rights Reserved.